Navigation Links
Colon cancer screening: Immunological tests are superior
Date:5/28/2013

For early detection of colorectal (colon) cancer, statutory health insurance in Germany offers a fecal occult blood test free of charge to all insured persons starting at 50 years of age. In addition, those 55 or older are entitled to an endoscopic examination of the colon (colonoscopy). Colonoscopy identifies precancerous lesions with a high level of exactitude. Nevertheless, only about 20-30 percent of those eligible actually take advantage of the screening examination. "Therefore, fecal occult blood tests are important, because they help us reach more people. People are much more willing to have a simple laboratory test. Hence it is all the more important for these tests to provide valuable results," says Professor Hermann Brenner from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).

The test covered by health insurance is based on the detection of enzymatic activity in fecal occult blood (a "stool guaiac test"). For several years now, immunological testing methods using antibodies to detect hemoglobin in stool samples have also been available. These tests are regarded as more sensitive; i.e., they are believed to detect more tissue abnormalities. Until now, however, the two methods have only been compared in a few small-scale studies.

Hermann Brenner and his coworker Sha Tao have now directly compared the two methods in a large-scale study for the first time. 2,235 participants who underwent colon cancer screening colonoscopies between 2005 and 2009 provided stool samples immediately prior to the examination. These were tested for occult blood using both methods. Subsequently, the DKFZ researchers analyzed the test results by comparing them with the results from colonoscopies.

The enzyme-based test detected one third of all colon cancer cases, about nine percent of advanced precancerous lesions (adenomas), and about five percent of early precancerous lesions. The specificity was slightly over 95 percent: In 95 out of 100 participants with negative test results, no tissue abnormalities were found in the subsequent colonoscopy.

However, the three immunological tests* that were used detected about twice as many cancer cases (60.0, 53.3 and 73.3 percent) and about three times as many advanced precancerous lesions, with a specificity that was a little higher than enzymatic testing.

Only one third (31 percent) of all positive results from enzymatic testing were in fact the result of a tissue abnormality. By contrast, colonoscopy confirmed the presence of an abnormality in about two thirds (57 to 68 percent) of positive results obtained by immunological testing. "Immunological tests can thus help encourage people with a positive finding to undertake a colonoscopy afterwards, meaning that those individuals who actually have precancerous lesions would likely participate in colonoscopy screening," explains Brenner.

The enzymatic test only provides a positive or negative result, whereas the immunological test quantifies hemoglobin levels. The researchers therefore had to make the results comparable by defining threshold values for the immunological tests such that both methods delivered the same number of positive results.

"For the first time we have shown by direct comparison that the diagnostic performance of immunological stool tests is significantly higher than that of the enzymatic test at the same rate of positive results," says Hermann Brenner. He hopes that his research will provide a convincing argument to health-care policy makers. "Tests for occult blood in the stool will continue to be an important part of colon cancer screening. We therefore recommend including immunological tests in cancer screening programs in Germany. Many more people would thus benefit by obtaining a life-saving clue pointing to a hidden case of cancer."

In a number of European countries that offer cancer screening programs, immunological tests have already become the standard. Besides higher sensitivity, they offer further practical advantages: They can be more easily automated, and participants do not have to avoid certain types of food prior to the test, because the antibodies react specifically to human hemoglobin. Brenner is convinced that the slightly higher costs of immunological testing will fall once the tests can be produced on a large scale.


'/>"/>

Contact: Dr. Sibylle Kohlstädt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Related medicine news :

1. hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer
2. New Device May Show Doctors More of the Colon
3. New smartphone application improves colonoscopy preparation
4. New colonoscope provides ground-breaking view of colon
5. The Surgeons of Los Angeles Colon and Rectal Surgical Associates are Now Offering Exparel for Use in Local Anesthesia During Anorectal Operations
6. Sea Colony Tennis Center Announces May and June USTA Sponsored Events
7. Sea Colony Ranked No. 15 Tennis Camp in the World by Tennis Resorts Online
8. Women Smokers More Likely to Get Colon Cancer Than Men: Study
9. Women smokers may have greater risk for colon cancer than men
10. Calcium May Cut Risk for Precancerous Colon Lesions in Some People
11. New Article Detailing Probiotics for Gut and Colon Health Published by eProbiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... On Sunday, May 15, Rockynol ... 64-room assisted living center. After 18 months of construction, the new state-of-the-art structure ... building provides the latest in assisted living amenities and services, offering six different ...
(Date:5/23/2016)... Los Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... bariatric surgeons have noted that, less than 1% of United Kingdom residents who could ... the UK’s National Health Service (NHS) increases the number of bariatric procedures it offers ...
(Date:5/23/2016)... ... May 23, 2016 , ... African-American ... to Georgia State University researchers. , In a recent study published ... and seventh grades shared their experiences with strained relationships, recurring violence, internalized ...
(Date:5/23/2016)... ... May 23, 2016 , ... ComplianceOnline, the leading governance, risk ... medical device summit on September 15 and 16, 2016 in San Diego, CA. ... FDA office bearers will be one of the largest gatherings of medical device companies, ...
(Date:5/23/2016)... PALMYRA, Wis. (PRWEB) , ... May 23, 2016 ... ... held April 29 on its Chesterfield, Missouri, campus, Standard Process Inc. ... Kate Cline, Stephanie Siewert and Chloe Tillman. Each student is in her fifth ...
Breaking Medicine News(10 mins):
(Date:5/20/2016)... , May 20, 2016 ... Antibody Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors ... Drugs - This New Study Reveals Selling Opportunities ... ,What is the future of ... latest technological and commercial analysis. Staying ahead in ...
(Date:5/19/2016)... , May 19, 2016  According to the ... the world lacks basic diagnostic imaging. Whereas mammography ... the United States , many places ... technology. In fact, the WHO reports that those ... avoidable or treatable death, simply due to the ...
(Date:5/19/2016)... , May 19, 2016 According to a ... 2016-2017, G7 Countries, (U.S., Germany , ... Spain , and Japan )", published by ... 2021, at a CAGR of 13.9% from 2016 to 2021. ... Browse 14 market data Tables spread through 26 Pages and in-depth ...
Breaking Medicine Technology: